BRIGHT MINDS BIOSCIENCES INC.
For the period ended Sep 30, 2025. Filed Dec 23, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Dec 23, 2025
Use the contents to explore the available documents and sections.
Contents
CODE OF ETHICS
We have adopted a Code of Business Conduct and Ethics (the "Code") that applies to all of our employees and officers, (including without limitation, the CEO and CFO), and its subsidiaries and promotes, among other things, honest and ethical conduct. The Code meets the requirements for a "code of ethics" within the meaning of that term in Form 40-F.
The Code was reviewed and approved by the Board on June 13, 2021. The Code is available on the Company's corporate website atwww.brightmindsbio.com and under the Company's SEDAR+ profile onwww.sedarplus.ca and is filed as Exhibit 99.7 to this Annual Report. The Company will provide the Code to any person who requests a copy, without charge. Any person who wishes for a copy of the Code should email their request toinfo@brightmindsbio.com.
During the financial year ended September 30, 2025, no material amendment was made to the Code which would be required to be disclosed pursuant to Paragraph 9 of General Instruction B, and no waivers of the Code were granted to any principal officer of the Company or any person performing similar functions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.